CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 84 enrolled
Drug / intervention
Nabilone +1 moredrug
Likely dose
Nabilone 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01347762
NCT01347762Phase 3Completed

Nabilone for Cannabis Dependence: A Pilot Study

Mclean Hospital·interventional·Posted May 4, 2011·Updated Jun 1, 2018

In Brief

A Phase 3 clinical trial evaluating Nabilone and Placebo for Cannabis Dependence and Marijuana Dependence. Completed, enrolled 84 participants across 1 site.

Detailed Summary

Cannabis use disorders are an important public health problem in the United States, but there are no effective medications available to treat these disorders. The investigators intend to test a medication with interesting properties, nabilone, as a treatment for cannabis dependence and to study the relationship of this treatment with the brain using functional MRI brain scans. Nabilone and marijuana have similar effects upon behaviors and the human body, suggesting that nabilone may decrease cannabis withdrawal symptoms while allowing treatment-seeking patients to benefit from behavioral treatments when they are trying to stop using cannabis. The investigators propose to assess the relationship of nabilone, when added to behavioral treatment, on cannabis use patterns in cannabis-dependent patients. The investigators also aim to determine the effects of nabilone on performance on neuropsychological tests and to assess the correlation of neuropsychological performance to brain changes using functional MRI brain scans. The investigators hypothesize that patients receiving nabilone will reduce their use of cannabis more than patients receiving placebo during this 10-week treatment trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 4, 2011
Enrollment StartJun 1, 2010
Primary CompletionJun 9, 2017
TodayJul 2, 2026
Enrollment to primary: 7.0 yearsPosted 15.2 years ago

Interventions

Nabilonedrug

nabilone titrated to 1 mg by mouth twice daily

Placebodrug

one placebo capsule by mouth twice daily